Stay updated on Dabrafenib/Trametinib in BRAF V600E+ Rare Cancers Clinical Trial

Sign up to get notified when there's something new on the Dabrafenib/Trametinib in BRAF V600E+ Rare Cancers Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Dabrafenib/Trametinib in BRAF V600E+ Rare Cancers Clinical Trial page

  1. Check
    7 days ago
    No Change Detected
  2. Check
    14 days ago
    Change Detected
    Summary
    Added Revision: v3.4.2 and removed Revision: v3.4.1 in the website_changes section.
    Difference
    0.0%
    Check dated 2026-02-13T12:59:11.000Z thumbnail image
  3. Check
    21 days ago
    Change Detected
    Summary
    Revision updated from v3.4.0 to v3.4.1. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.0%
    Check dated 2026-02-06T09:19:33.000Z thumbnail image
  4. Check
    43 days ago
    Change Detected
    Summary
    Only a metadata revision was updated (Revision: v3.3.4 replacing v3.3.3); no study content or documents are affected. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.0%
    Check dated 2026-01-15T04:11:14.000Z thumbnail image
  5. Check
    65 days ago
    Change Detected
    Summary
    Locations section updated with new sites in Arkansas, California, Maryland, Massachusetts, New York, Tennessee, Texas, Ontario, Baden-Wurttemberg, and Lombardy; corresponding regional 'Locations' entries were removed.
    Difference
    0.8%
    Check dated 2025-12-24T15:18:44.000Z thumbnail image
  6. Check
    95 days ago
    Change Detected
    Summary
    Added a note indicating PubMed auto-filled publications. Updated the revision to v3.3.2; the old PubMed wording tied to v3.2.0 was removed.
    Difference
    0.1%
    Check dated 2025-11-24T17:53:18.000Z thumbnail image
  7. Check
    102 days ago
    Change Detected
    Summary
    Removed the funding-lapse notice that warned about possible delays in updates and operations. The page no longer displays guidance on government funding status or response times.
    Difference
    0.2%
    Check dated 2025-11-17T17:48:41.000Z thumbnail image

Stay in the know with updates to Dabrafenib/Trametinib in BRAF V600E+ Rare Cancers Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Dabrafenib/Trametinib in BRAF V600E+ Rare Cancers Clinical Trial page.